BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 5000190)

  • 1. In vivo properties of attenuated rubella virus, "Cendehill" strain.
    Zygraich N; Peetermans J; Huygelen C
    Arch Gesamte Virusforsch; 1971; 33(3):225-33. PubMed ID: 5000190
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety testing of rubella virus vaccine (Cendehill strain). Preparation in primary rabbit kidney cells.
    Huygelen C; Sigel MM; Zygraich N; Peetermans JH; Colinet G; Leyten R; Raupp WG; Pinto CA; Garg SG; Boyle JJ; Haff RF
    Am J Dis Child; 1969 Aug; 118(2):362-6. PubMed ID: 4978514
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic stability in humans of the rabbit immunogenic marker of Cendehill rubella vaccine virus.
    Gill SD; Furesz J
    Arch Gesamte Virusforsch; 1973; 43(1):135-43. PubMed ID: 4793528
    [No Abstract]   [Full Text] [Related]  

  • 4. Production of rubella virus vaccine. Live, attenuated in canine renal cell cultures.
    Musser SJ; Hilsabeck LJ
    Am J Dis Child; 1969 Aug; 118(2):355-61. PubMed ID: 4978513
    [No Abstract]   [Full Text] [Related]  

  • 5. An attenuated rubella virus vaccine (Cendehill 51 strain) grown in primary rabbit kidney cells.
    Huygelen C; Peetermans J; Prinzie A
    Prog Med Virol; 1969; 11():107-25. PubMed ID: 4984707
    [No Abstract]   [Full Text] [Related]  

  • 6. An immunologic marker technique for the Cendehill vaccine strain of rubella virus.
    Oxford JS; Potter CW
    J Immunol; 1970 Oct; 105(4):818-23. PubMed ID: 5470523
    [No Abstract]   [Full Text] [Related]  

  • 7. Live attenuated rubella virus vaccines prepared in duck embryo cell culture. I. Development and clinical testing.
    Buynak EB; Hilleman MR; Weibel RE; Stokes J
    JAMA; 1968 Apr; 204(3):195-200. PubMed ID: 4172467
    [No Abstract]   [Full Text] [Related]  

  • 8. Attenuated rubella viruses. Laboratory and clinical characteristics.
    Meyer HM; Parkman PD; Hobbins TE; Larson HE; Davis WJ; Simsarian JP; Hopps HE
    Am J Dis Child; 1969 Aug; 118(2):155-65. PubMed ID: 4978508
    [No Abstract]   [Full Text] [Related]  

  • 9. Live attenuated rubella virus vaccines. Experiences with duck embryo cell preparations.
    Hilleman MR; Buynak EB; Whitman JE; Weibel RW; Stokes J
    Am J Dis Child; 1969 Aug; 118(2):166-71. PubMed ID: 5815860
    [No Abstract]   [Full Text] [Related]  

  • 10. Attenuation of RA 27-3 rubella virus in WI-38 human diploid cells.
    Plotkin SA; Farquhar JD; Katz M; Buser F
    Am J Dis Child; 1969 Aug; 118(2):178-85. PubMed ID: 5794813
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemagglutination inhibition reaction with rubella virus using erythrocytes from different species and different concentrations of antigen].
    Desiatskova RG; Opochinskiĭ EF
    Vopr Virusol; 1972; 17(5):627-31. PubMed ID: 4628717
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospects for a rubella virus vaccine.
    Parkman PD; Meyer HM
    Prog Med Virol; 1969; 11():80-106. PubMed ID: 4984711
    [No Abstract]   [Full Text] [Related]  

  • 13. Live attenuated rubella virus vaccines in young adult women. Trials of Cendehill and HPV-77 DE-5.
    Byrne EB; Ryan JM; Randolph MF; Horstmann DM
    Am J Dis Child; 1969 Aug; 118(2):234-6. PubMed ID: 4183351
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial of live attenuated rubella virus vaccine, HPV-77 strain.
    Cooper LZ; Giles JP; Krugman S
    Am J Dis Child; 1968 Jun; 115(6):655-7. PubMed ID: 4968322
    [No Abstract]   [Full Text] [Related]  

  • 15. Trials with a live attenuated rubella virus vaccine, Cendehill strain.
    Grant L; Belle EA; Provan G; King SD; Sigel MM
    J Hyg (Lond); 1970 Sep; 68(3):505-10. PubMed ID: 5272349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of an attenuated rubella virus strain (Cendehill).
    Huygelen C; Peetermans J
    Prog Immunobiol Stand; 1967; 3():181-7. PubMed ID: 4985508
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on live rubella vaccine. I. Propagation of rubella virus in developing chick embryos and its laboratory characterization.
    Okuno Y; Minekawa Y; Suzuki N; Takahashi M
    Biken J; 1968 Dec; 11(4):235-42. PubMed ID: 4976546
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.
    Ogra PL; Kerr-Grant D; Umana G; Dzierba J; Weintraub D
    N Engl J Med; 1971 Dec; 285(24):1333-9. PubMed ID: 4107718
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molecular and biologic characteristics of attenuated rubella viruses].
    Lavrent'eva IN
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (4):55-9. PubMed ID: 18819408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response in school children to live rubella vaccine (Cendehill strain).
    Iwakata S; Elkerton LE; Rhodes AJ; Bull JA; Labzoffsky NA
    Can Med Assoc J; 1972 May; 106(9):980-2. PubMed ID: 4554732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.